amsacrine has been researched along with Bilirubinemia in 2 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amsacrine, 90 mg/m2, was given daily for 5-8 days to 45 patients with acute myeloblastic leukemia, 15 patients with acute lymphoblastic leukemia, and six patients with blastic transformation of chronic granulocytic leukemia." | 1.27 | Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group. ( Hearn, EB; Johnson, L; Logan, T; Raney, M; Vogler, WR; Winton, EF, 1983) |
| "Patients with acute leukemia in relapse were given 5'-(9-acridinylamino)methanesulfon-m-anisidide at a dosage of 75 to 200 mg/sq m as a daily bolus infusion of 5 consecutive days." | 1.26 | Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia. ( Arlin, ZA; Clarkson, BD; Gee, TS; Howard, J; Kempin, SJ; Sklaroff, RB; Young, CW, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Winton, EF | 1 |
| Hearn, EB | 1 |
| Vogler, WR | 1 |
| Johnson, L | 1 |
| Logan, T | 1 |
| Raney, M | 1 |
| Arlin, ZA | 1 |
| Sklaroff, RB | 1 |
| Gee, TS | 1 |
| Kempin, SJ | 1 |
| Howard, J | 1 |
| Clarkson, BD | 1 |
| Young, CW | 1 |
2 other studies available for amsacrine and Bilirubinemia
| Article | Year |
|---|---|
Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
Topics: Adolescent; Adult; Aged; Aminoacridines; Amsacrine; Bone Marrow; Drug Evaluation; Female; Humans; Hy | 1983 |
Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Drug Administration Schedule; Drug Evaluation; Humans; | 1980 |